Global Gene-Deleted Vaccines Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
A Gene Deletion Vaccine is a vaccine developed without the ability to replicate by deleting important genes.These substances are very harmless because they cannot be released into the environment.Another benefit of live vaccines is that they can often be delivered via the mucosal route, which is a natural route of infection, thereby inducing mucosal immunity through systemic immunity.By increasing mucosal immunity, disease progression can be halted at the onset of infection.
LPI (LP Information)' newest research report, the “Gene-Deleted Vaccines Industry Forecast” looks at past sales and reviews total world Gene-Deleted Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene-Deleted Vaccines sales for 2023 through 2029. With Gene-Deleted Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-Deleted Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Gene-Deleted Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene-Deleted Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene-Deleted Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-Deleted Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-Deleted Vaccines.
The global Gene-Deleted Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene-Deleted Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene-Deleted Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene-Deleted Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene-Deleted Vaccines players cover Virbac SA, Merck Animal Health, Zoetis Inc, Boehringer Ingelheim GmbH, Ceva, Bayer, Biogenesis-Bago, Indian Immunologicals Ltd and Heska Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene-Deleted Vaccines market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
A Gene Deletion Vaccine is a vaccine developed without the ability to replicate by deleting important genes.These substances are very harmless because they cannot be released into the environment.Another benefit of live vaccines is that they can often be delivered via the mucosal route, which is a natural route of infection, thereby inducing mucosal immunity through systemic immunity.By increasing mucosal immunity, disease progression can be halted at the onset of infection.
LPI (LP Information)' newest research report, the “Gene-Deleted Vaccines Industry Forecast” looks at past sales and reviews total world Gene-Deleted Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene-Deleted Vaccines sales for 2023 through 2029. With Gene-Deleted Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-Deleted Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Gene-Deleted Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene-Deleted Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene-Deleted Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-Deleted Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-Deleted Vaccines.
The global Gene-Deleted Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene-Deleted Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene-Deleted Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene-Deleted Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene-Deleted Vaccines players cover Virbac SA, Merck Animal Health, Zoetis Inc, Boehringer Ingelheim GmbH, Ceva, Bayer, Biogenesis-Bago, Indian Immunologicals Ltd and Heska Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene-Deleted Vaccines market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Single Gene Deleted Vaccine
- Double Gene Deleted Vaccine
- Veterinary Hospitals
- Veterinary Clinics
- Animal Care Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Virbac SA
- Merck Animal Health
- Zoetis Inc
- Boehringer Ingelheim GmbH
- Ceva
- Bayer
- Biogenesis-Bago
- Indian Immunologicals Ltd
- Heska Corporation
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-Deleted Vaccines Market Size 2018-2029
2.1.2 Gene-Deleted Vaccines Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene-Deleted Vaccines Segment by Type
2.2.1 Single Gene Deleted Vaccine
2.2.2 Double Gene Deleted Vaccine
2.3 Gene-Deleted Vaccines Market Size by Type
2.3.1 Gene-Deleted Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
2.4 Gene-Deleted Vaccines Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Animal Care Centers
2.4.4 Others
2.5 Gene-Deleted Vaccines Market Size by Application
2.5.1 Gene-Deleted Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
3 GENE-DELETED VACCINES MARKET SIZE BY PLAYER
3.1 Gene-Deleted Vaccines Market Size Market Share by Players
3.1.1 Global Gene-Deleted Vaccines Revenue by Players (2018-2023)
3.1.2 Global Gene-Deleted Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Gene-Deleted Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-DELETED VACCINES BY REGIONS
4.1 Gene-Deleted Vaccines Market Size by Regions (2018-2023)
4.2 Americas Gene-Deleted Vaccines Market Size Growth (2018-2023)
4.3 APAC Gene-Deleted Vaccines Market Size Growth (2018-2023)
4.4 Europe Gene-Deleted Vaccines Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene-Deleted Vaccines Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene-Deleted Vaccines Market Size by Country (2018-2023)
5.2 Americas Gene-Deleted Vaccines Market Size by Type (2018-2023)
5.3 Americas Gene-Deleted Vaccines Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-Deleted Vaccines Market Size by Region (2018-2023)
6.2 APAC Gene-Deleted Vaccines Market Size by Type (2018-2023)
6.3 APAC Gene-Deleted Vaccines Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-Deleted Vaccines by Country (2018-2023)
7.2 Europe Gene-Deleted Vaccines Market Size by Type (2018-2023)
7.3 Europe Gene-Deleted Vaccines Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-Deleted Vaccines by Region (2018-2023)
8.2 Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-DELETED VACCINES MARKET FORECAST
10.1 Global Gene-Deleted Vaccines Forecast by Regions (2024-2029)
10.1.1 Global Gene-Deleted Vaccines Forecast by Regions (2024-2029)
10.1.2 Americas Gene-Deleted Vaccines Forecast
10.1.3 APAC Gene-Deleted Vaccines Forecast
10.1.4 Europe Gene-Deleted Vaccines Forecast
10.1.5 Middle East & Africa Gene-Deleted Vaccines Forecast
10.2 Americas Gene-Deleted Vaccines Forecast by Country (2024-2029)
10.2.1 United States Gene-Deleted Vaccines Market Forecast
10.2.2 Canada Gene-Deleted Vaccines Market Forecast
10.2.3 Mexico Gene-Deleted Vaccines Market Forecast
10.2.4 Brazil Gene-Deleted Vaccines Market Forecast
10.3 APAC Gene-Deleted Vaccines Forecast by Region (2024-2029)
10.3.1 China Gene-Deleted Vaccines Market Forecast
10.3.2 Japan Gene-Deleted Vaccines Market Forecast
10.3.3 Korea Gene-Deleted Vaccines Market Forecast
10.3.4 Southeast Asia Gene-Deleted Vaccines Market Forecast
10.3.5 India Gene-Deleted Vaccines Market Forecast
10.3.6 Australia Gene-Deleted Vaccines Market Forecast
10.4 Europe Gene-Deleted Vaccines Forecast by Country (2024-2029)
10.4.1 Germany Gene-Deleted Vaccines Market Forecast
10.4.2 France Gene-Deleted Vaccines Market Forecast
10.4.3 UK Gene-Deleted Vaccines Market Forecast
10.4.4 Italy Gene-Deleted Vaccines Market Forecast
10.4.5 Russia Gene-Deleted Vaccines Market Forecast
10.5 Middle East & Africa Gene-Deleted Vaccines Forecast by Region (2024-2029)
10.5.1 Egypt Gene-Deleted Vaccines Market Forecast
10.5.2 South Africa Gene-Deleted Vaccines Market Forecast
10.5.3 Israel Gene-Deleted Vaccines Market Forecast
10.5.4 Turkey Gene-Deleted Vaccines Market Forecast
10.5.5 GCC Countries Gene-Deleted Vaccines Market Forecast
10.6 Global Gene-Deleted Vaccines Forecast by Type (2024-2029)
10.7 Global Gene-Deleted Vaccines Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Virbac SA
11.1.1 Virbac SA Company Information
11.1.2 Virbac SA Gene-Deleted Vaccines Product Offered
11.1.3 Virbac SA Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Virbac SA Main Business Overview
11.1.5 Virbac SA Latest Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Information
11.2.2 Merck Animal Health Gene-Deleted Vaccines Product Offered
11.2.3 Merck Animal Health Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck Animal Health Main Business Overview
11.2.5 Merck Animal Health Latest Developments
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Information
11.3.2 Zoetis Inc Gene-Deleted Vaccines Product Offered
11.3.3 Zoetis Inc Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zoetis Inc Main Business Overview
11.3.5 Zoetis Inc Latest Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Information
11.4.2 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product Offered
11.4.3 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Boehringer Ingelheim GmbH Main Business Overview
11.4.5 Boehringer Ingelheim GmbH Latest Developments
11.5 Ceva
11.5.1 Ceva Company Information
11.5.2 Ceva Gene-Deleted Vaccines Product Offered
11.5.3 Ceva Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Ceva Main Business Overview
11.5.5 Ceva Latest Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer Gene-Deleted Vaccines Product Offered
11.6.3 Bayer Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bayer Main Business Overview
11.6.5 Bayer Latest Developments
11.7 Biogenesis-Bago
11.7.1 Biogenesis-Bago Company Information
11.7.2 Biogenesis-Bago Gene-Deleted Vaccines Product Offered
11.7.3 Biogenesis-Bago Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Biogenesis-Bago Main Business Overview
11.7.5 Biogenesis-Bago Latest Developments
11.8 Indian Immunologicals Ltd
11.8.1 Indian Immunologicals Ltd Company Information
11.8.2 Indian Immunologicals Ltd Gene-Deleted Vaccines Product Offered
11.8.3 Indian Immunologicals Ltd Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Indian Immunologicals Ltd Main Business Overview
11.8.5 Indian Immunologicals Ltd Latest Developments
11.9 Heska Corporation
11.9.1 Heska Corporation Company Information
11.9.2 Heska Corporation Gene-Deleted Vaccines Product Offered
11.9.3 Heska Corporation Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Heska Corporation Main Business Overview
11.9.5 Heska Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-Deleted Vaccines Market Size 2018-2029
2.1.2 Gene-Deleted Vaccines Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene-Deleted Vaccines Segment by Type
2.2.1 Single Gene Deleted Vaccine
2.2.2 Double Gene Deleted Vaccine
2.3 Gene-Deleted Vaccines Market Size by Type
2.3.1 Gene-Deleted Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
2.4 Gene-Deleted Vaccines Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Animal Care Centers
2.4.4 Others
2.5 Gene-Deleted Vaccines Market Size by Application
2.5.1 Gene-Deleted Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
3 GENE-DELETED VACCINES MARKET SIZE BY PLAYER
3.1 Gene-Deleted Vaccines Market Size Market Share by Players
3.1.1 Global Gene-Deleted Vaccines Revenue by Players (2018-2023)
3.1.2 Global Gene-Deleted Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Gene-Deleted Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-DELETED VACCINES BY REGIONS
4.1 Gene-Deleted Vaccines Market Size by Regions (2018-2023)
4.2 Americas Gene-Deleted Vaccines Market Size Growth (2018-2023)
4.3 APAC Gene-Deleted Vaccines Market Size Growth (2018-2023)
4.4 Europe Gene-Deleted Vaccines Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene-Deleted Vaccines Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene-Deleted Vaccines Market Size by Country (2018-2023)
5.2 Americas Gene-Deleted Vaccines Market Size by Type (2018-2023)
5.3 Americas Gene-Deleted Vaccines Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-Deleted Vaccines Market Size by Region (2018-2023)
6.2 APAC Gene-Deleted Vaccines Market Size by Type (2018-2023)
6.3 APAC Gene-Deleted Vaccines Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-Deleted Vaccines by Country (2018-2023)
7.2 Europe Gene-Deleted Vaccines Market Size by Type (2018-2023)
7.3 Europe Gene-Deleted Vaccines Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-Deleted Vaccines by Region (2018-2023)
8.2 Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-DELETED VACCINES MARKET FORECAST
10.1 Global Gene-Deleted Vaccines Forecast by Regions (2024-2029)
10.1.1 Global Gene-Deleted Vaccines Forecast by Regions (2024-2029)
10.1.2 Americas Gene-Deleted Vaccines Forecast
10.1.3 APAC Gene-Deleted Vaccines Forecast
10.1.4 Europe Gene-Deleted Vaccines Forecast
10.1.5 Middle East & Africa Gene-Deleted Vaccines Forecast
10.2 Americas Gene-Deleted Vaccines Forecast by Country (2024-2029)
10.2.1 United States Gene-Deleted Vaccines Market Forecast
10.2.2 Canada Gene-Deleted Vaccines Market Forecast
10.2.3 Mexico Gene-Deleted Vaccines Market Forecast
10.2.4 Brazil Gene-Deleted Vaccines Market Forecast
10.3 APAC Gene-Deleted Vaccines Forecast by Region (2024-2029)
10.3.1 China Gene-Deleted Vaccines Market Forecast
10.3.2 Japan Gene-Deleted Vaccines Market Forecast
10.3.3 Korea Gene-Deleted Vaccines Market Forecast
10.3.4 Southeast Asia Gene-Deleted Vaccines Market Forecast
10.3.5 India Gene-Deleted Vaccines Market Forecast
10.3.6 Australia Gene-Deleted Vaccines Market Forecast
10.4 Europe Gene-Deleted Vaccines Forecast by Country (2024-2029)
10.4.1 Germany Gene-Deleted Vaccines Market Forecast
10.4.2 France Gene-Deleted Vaccines Market Forecast
10.4.3 UK Gene-Deleted Vaccines Market Forecast
10.4.4 Italy Gene-Deleted Vaccines Market Forecast
10.4.5 Russia Gene-Deleted Vaccines Market Forecast
10.5 Middle East & Africa Gene-Deleted Vaccines Forecast by Region (2024-2029)
10.5.1 Egypt Gene-Deleted Vaccines Market Forecast
10.5.2 South Africa Gene-Deleted Vaccines Market Forecast
10.5.3 Israel Gene-Deleted Vaccines Market Forecast
10.5.4 Turkey Gene-Deleted Vaccines Market Forecast
10.5.5 GCC Countries Gene-Deleted Vaccines Market Forecast
10.6 Global Gene-Deleted Vaccines Forecast by Type (2024-2029)
10.7 Global Gene-Deleted Vaccines Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Virbac SA
11.1.1 Virbac SA Company Information
11.1.2 Virbac SA Gene-Deleted Vaccines Product Offered
11.1.3 Virbac SA Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Virbac SA Main Business Overview
11.1.5 Virbac SA Latest Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Information
11.2.2 Merck Animal Health Gene-Deleted Vaccines Product Offered
11.2.3 Merck Animal Health Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck Animal Health Main Business Overview
11.2.5 Merck Animal Health Latest Developments
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Information
11.3.2 Zoetis Inc Gene-Deleted Vaccines Product Offered
11.3.3 Zoetis Inc Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zoetis Inc Main Business Overview
11.3.5 Zoetis Inc Latest Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Information
11.4.2 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product Offered
11.4.3 Boehringer Ingelheim GmbH Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Boehringer Ingelheim GmbH Main Business Overview
11.4.5 Boehringer Ingelheim GmbH Latest Developments
11.5 Ceva
11.5.1 Ceva Company Information
11.5.2 Ceva Gene-Deleted Vaccines Product Offered
11.5.3 Ceva Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Ceva Main Business Overview
11.5.5 Ceva Latest Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer Gene-Deleted Vaccines Product Offered
11.6.3 Bayer Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bayer Main Business Overview
11.6.5 Bayer Latest Developments
11.7 Biogenesis-Bago
11.7.1 Biogenesis-Bago Company Information
11.7.2 Biogenesis-Bago Gene-Deleted Vaccines Product Offered
11.7.3 Biogenesis-Bago Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Biogenesis-Bago Main Business Overview
11.7.5 Biogenesis-Bago Latest Developments
11.8 Indian Immunologicals Ltd
11.8.1 Indian Immunologicals Ltd Company Information
11.8.2 Indian Immunologicals Ltd Gene-Deleted Vaccines Product Offered
11.8.3 Indian Immunologicals Ltd Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Indian Immunologicals Ltd Main Business Overview
11.8.5 Indian Immunologicals Ltd Latest Developments
11.9 Heska Corporation
11.9.1 Heska Corporation Company Information
11.9.2 Heska Corporation Gene-Deleted Vaccines Product Offered
11.9.3 Heska Corporation Gene-Deleted Vaccines Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Heska Corporation Main Business Overview
11.9.5 Heska Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene-Deleted Vaccines Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Single Gene Deleted Vaccine
Table 3. Major Players of Double Gene Deleted Vaccine
Table 4. Gene-Deleted Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 7. Gene-Deleted Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 10. Global Gene-Deleted Vaccines Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene-Deleted Vaccines Revenue Market Share by Player (2018-2023)
Table 12. Gene-Deleted Vaccines Key Players Head office and Products Offered
Table 13. Gene-Deleted Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene-Deleted Vaccines Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene-Deleted Vaccines Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene-Deleted Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene-Deleted Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene-Deleted Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene-Deleted Vaccines Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene-Deleted Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene-Deleted Vaccines Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene-Deleted Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene-Deleted Vaccines Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene-Deleted Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene-Deleted Vaccines
Table 45. Key Market Challenges & Risks of Gene-Deleted Vaccines
Table 46. Key Industry Trends of Gene-Deleted Vaccines
Table 47. Global Gene-Deleted Vaccines Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene-Deleted Vaccines Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene-Deleted Vaccines Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene-Deleted Vaccines Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Virbac SA Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 52. Virbac SA Gene-Deleted Vaccines Product Offered
Table 53. Virbac SA Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Virbac SA Main Business
Table 55. Virbac SA Latest Developments
Table 56. Merck Animal Health Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 57. Merck Animal Health Gene-Deleted Vaccines Product Offered
Table 58. Merck Animal Health Main Business
Table 59. Merck Animal Health Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Merck Animal Health Latest Developments
Table 61. Zoetis Inc Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 62. Zoetis Inc Gene-Deleted Vaccines Product Offered
Table 63. Zoetis Inc Main Business
Table 64. Zoetis Inc Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Inc Latest Developments
Table 66. Boehringer Ingelheim GmbH Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 67. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product Offered
Table 68. Boehringer Ingelheim GmbH Main Business
Table 69. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Boehringer Ingelheim GmbH Latest Developments
Table 71. Ceva Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 72. Ceva Gene-Deleted Vaccines Product Offered
Table 73. Ceva Main Business
Table 74. Ceva Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Ceva Latest Developments
Table 76. Bayer Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 77. Bayer Gene-Deleted Vaccines Product Offered
Table 78. Bayer Main Business
Table 79. Bayer Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Bayer Latest Developments
Table 81. Biogenesis-Bago Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 82. Biogenesis-Bago Gene-Deleted Vaccines Product Offered
Table 83. Biogenesis-Bago Main Business
Table 84. Biogenesis-Bago Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Biogenesis-Bago Latest Developments
Table 86. Indian Immunologicals Ltd Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 87. Indian Immunologicals Ltd Gene-Deleted Vaccines Product Offered
Table 88. Indian Immunologicals Ltd Main Business
Table 89. Indian Immunologicals Ltd Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Indian Immunologicals Ltd Latest Developments
Table 91. Heska Corporation Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 92. Heska Corporation Gene-Deleted Vaccines Product Offered
Table 93. Heska Corporation Main Business
Table 94. Heska Corporation Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Heska Corporation Latest Developments
Table 1. Gene-Deleted Vaccines Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Single Gene Deleted Vaccine
Table 3. Major Players of Double Gene Deleted Vaccine
Table 4. Gene-Deleted Vaccines Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 7. Gene-Deleted Vaccines Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 10. Global Gene-Deleted Vaccines Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene-Deleted Vaccines Revenue Market Share by Player (2018-2023)
Table 12. Gene-Deleted Vaccines Key Players Head office and Products Offered
Table 13. Gene-Deleted Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene-Deleted Vaccines Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene-Deleted Vaccines Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene-Deleted Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene-Deleted Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene-Deleted Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene-Deleted Vaccines Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene-Deleted Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene-Deleted Vaccines Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene-Deleted Vaccines Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene-Deleted Vaccines Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene-Deleted Vaccines Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene-Deleted Vaccines Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene-Deleted Vaccines Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene-Deleted Vaccines
Table 45. Key Market Challenges & Risks of Gene-Deleted Vaccines
Table 46. Key Industry Trends of Gene-Deleted Vaccines
Table 47. Global Gene-Deleted Vaccines Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene-Deleted Vaccines Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene-Deleted Vaccines Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene-Deleted Vaccines Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Virbac SA Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 52. Virbac SA Gene-Deleted Vaccines Product Offered
Table 53. Virbac SA Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Virbac SA Main Business
Table 55. Virbac SA Latest Developments
Table 56. Merck Animal Health Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 57. Merck Animal Health Gene-Deleted Vaccines Product Offered
Table 58. Merck Animal Health Main Business
Table 59. Merck Animal Health Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Merck Animal Health Latest Developments
Table 61. Zoetis Inc Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 62. Zoetis Inc Gene-Deleted Vaccines Product Offered
Table 63. Zoetis Inc Main Business
Table 64. Zoetis Inc Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Inc Latest Developments
Table 66. Boehringer Ingelheim GmbH Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 67. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Product Offered
Table 68. Boehringer Ingelheim GmbH Main Business
Table 69. Boehringer Ingelheim GmbH Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Boehringer Ingelheim GmbH Latest Developments
Table 71. Ceva Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 72. Ceva Gene-Deleted Vaccines Product Offered
Table 73. Ceva Main Business
Table 74. Ceva Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Ceva Latest Developments
Table 76. Bayer Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 77. Bayer Gene-Deleted Vaccines Product Offered
Table 78. Bayer Main Business
Table 79. Bayer Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Bayer Latest Developments
Table 81. Biogenesis-Bago Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 82. Biogenesis-Bago Gene-Deleted Vaccines Product Offered
Table 83. Biogenesis-Bago Main Business
Table 84. Biogenesis-Bago Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Biogenesis-Bago Latest Developments
Table 86. Indian Immunologicals Ltd Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 87. Indian Immunologicals Ltd Gene-Deleted Vaccines Product Offered
Table 88. Indian Immunologicals Ltd Main Business
Table 89. Indian Immunologicals Ltd Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Indian Immunologicals Ltd Latest Developments
Table 91. Heska Corporation Details, Company Type, Gene-Deleted Vaccines Area Served and Its Competitors
Table 92. Heska Corporation Gene-Deleted Vaccines Product Offered
Table 93. Heska Corporation Main Business
Table 94. Heska Corporation Gene-Deleted Vaccines Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Heska Corporation Latest Developments
LIST OF FIGURES
Figure 1. Gene-Deleted Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-Deleted Vaccines Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene-Deleted Vaccines Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene-Deleted Vaccines Sales Market Share by Country/Region (2022)
Figure 8. Gene-Deleted Vaccines Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene-Deleted Vaccines Market Size Market Share by Type in 2022
Figure 10. Gene-Deleted Vaccines in Veterinary Hospitals
Figure 11. Global Gene-Deleted Vaccines Market: Veterinary Hospitals (2018-2023) & ($ Millions)
Figure 12. Gene-Deleted Vaccines in Veterinary Clinics
Figure 13. Global Gene-Deleted Vaccines Market: Veterinary Clinics (2018-2023) & ($ Millions)
Figure 14. Gene-Deleted Vaccines in Animal Care Centers
Figure 15. Global Gene-Deleted Vaccines Market: Animal Care Centers (2018-2023) & ($ Millions)
Figure 16. Gene-Deleted Vaccines in Others
Figure 17. Global Gene-Deleted Vaccines Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Gene-Deleted Vaccines Market Size Market Share by Application in 2022
Figure 19. Global Gene-Deleted Vaccines Revenue Market Share by Player in 2022
Figure 20. Global Gene-Deleted Vaccines Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 22. APAC Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 23. Europe Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 25. Americas Gene-Deleted Vaccines Value Market Share by Country in 2022
Figure 26. United States Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Gene-Deleted Vaccines Market Size Market Share by Region in 2022
Figure 31. APAC Gene-Deleted Vaccines Market Size Market Share by Type in 2022
Figure 32. APAC Gene-Deleted Vaccines Market Size Market Share by Application in 2022
Figure 33. China Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Gene-Deleted Vaccines Market Size Market Share by Country in 2022
Figure 40. Europe Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Figure 41. Europe Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Figure 42. Germany Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 56. APAC Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 57. Europe Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 59. United States Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 60. Canada Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 63. China Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 64. Japan Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 65. Korea Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 67. India Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 68. Australia Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 69. Germany Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 70. France Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 71. UK Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 72. Italy Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 73. Russia Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 74. Spain Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 77. Israel Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 80. Global Gene-Deleted Vaccines Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Gene-Deleted Vaccines Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene-Deleted Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-Deleted Vaccines Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene-Deleted Vaccines Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene-Deleted Vaccines Sales Market Share by Country/Region (2022)
Figure 8. Gene-Deleted Vaccines Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene-Deleted Vaccines Market Size Market Share by Type in 2022
Figure 10. Gene-Deleted Vaccines in Veterinary Hospitals
Figure 11. Global Gene-Deleted Vaccines Market: Veterinary Hospitals (2018-2023) & ($ Millions)
Figure 12. Gene-Deleted Vaccines in Veterinary Clinics
Figure 13. Global Gene-Deleted Vaccines Market: Veterinary Clinics (2018-2023) & ($ Millions)
Figure 14. Gene-Deleted Vaccines in Animal Care Centers
Figure 15. Global Gene-Deleted Vaccines Market: Animal Care Centers (2018-2023) & ($ Millions)
Figure 16. Gene-Deleted Vaccines in Others
Figure 17. Global Gene-Deleted Vaccines Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Gene-Deleted Vaccines Market Size Market Share by Application in 2022
Figure 19. Global Gene-Deleted Vaccines Revenue Market Share by Player in 2022
Figure 20. Global Gene-Deleted Vaccines Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 22. APAC Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 23. Europe Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Gene-Deleted Vaccines Market Size 2018-2023 ($ Millions)
Figure 25. Americas Gene-Deleted Vaccines Value Market Share by Country in 2022
Figure 26. United States Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Gene-Deleted Vaccines Market Size Market Share by Region in 2022
Figure 31. APAC Gene-Deleted Vaccines Market Size Market Share by Type in 2022
Figure 32. APAC Gene-Deleted Vaccines Market Size Market Share by Application in 2022
Figure 33. China Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Gene-Deleted Vaccines Market Size Market Share by Country in 2022
Figure 40. Europe Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Figure 41. Europe Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Figure 42. Germany Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Gene-Deleted Vaccines Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Gene-Deleted Vaccines Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 56. APAC Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 57. Europe Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 59. United States Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 60. Canada Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 63. China Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 64. Japan Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 65. Korea Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 67. India Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 68. Australia Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 69. Germany Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 70. France Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 71. UK Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 72. Italy Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 73. Russia Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 74. Spain Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 77. Israel Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Gene-Deleted Vaccines Market Size 2024-2029 ($ Millions)
Figure 80. Global Gene-Deleted Vaccines Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Gene-Deleted Vaccines Market Size Market Share Forecast by Application (2024-2029)
